March 24 2025 - Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Mon, 03/24/25 - 11:22 am
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Fierce Biotech
Mon, 03/24/25 - 11:20 am
Novo Nordisk
obesity
United Laboratories
triple G agonists
UBT251
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
CNBC
Mon, 03/24/25 - 11:18 am
23andMe
bankruptcy
Anne Wojcicki
Medtech
diagnostics
Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset
Fierce Biotech
Mon, 03/24/25 - 11:08 am
Mira Pharmaceuticals
M&A
Skny Pharmaceuticals
obesity
smoking cessation
Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge
Fierce Pharma
Mon, 03/24/25 - 11:07 am
Biogen
headquarters
Cambridge
Massachusetts
Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy
Fierce Pharma
Mon, 03/24/25 - 11:05 am
Novo Nordisk
Wegovy
NovoCare Pharmacy
obesity
Elypta’s urine test identifies 90% of recurrent kidney cancer cases
Clinical Trials Arena
Mon, 03/24/25 - 11:03 am
Elypta
diagnostics
kidney cancer
Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
MSN/Reuters
Mon, 03/24/25 - 11:02 am
Hypera Pharma
semaglutide
generics
Ozempic
Novo Nordisk
Pharmaceutical supply chain headed for $5.3B valuation
Yahoo Finance
Mon, 03/24/25 - 11:00 am
pharma industry
supply chain
Lilly, Novo expand DTC reach of obesity meds after compound win
Pharma Voice
Mon, 03/24/25 - 10:58 am
Eli Lilly
Novo Nordisk
obesity
DTC
Mounjaro
Wegovy
Phase 3 readout puts Opthea at risk of insolvency
Pharmaphorum
Mon, 03/24/25 - 10:57 am
Opthea
clinical trials
wet age-related macular degeneration
sozinibercept
MIT team develops 'years-long' drug delivery tech
Pharmaphorum
Mon, 03/24/25 - 10:56 am
MIT
drug delivery
Chimerix engaged with 7 other biopharmas before choosing Jazz’s $935M deal—here’s why it won
Fierce Biotech
Sun, 03/23/25 - 11:45 pm
Jazz Pharma
Chimerix
M&A
FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again
Fierce Pharma
Sun, 03/23/25 - 11:43 pm
Jiangsu Hengrui
Elevar Therapeutics
camrelizumab
FDA
cancer
Trump Allies Aim to Slash Drug Prices. The Pharma Industry Is in a Bind.
Barron's
Sun, 03/23/25 - 11:41 pm
Donald Trump
drug pricing
March 21 2025 - Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Fri, 03/21/25 - 11:45 am
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Yahoo/Reuters
Fri, 03/21/25 - 11:42 am
gene therapy
rare disease
cancer
obesity
weight loss
drug development
MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data
Fierce Biotech
Fri, 03/21/25 - 11:39 am
Macrogenics
vobra duo
clinical trials
Potential impacts of the US withdrawal from the WHO on clinical trials globally
Clinical Trials Arena
Fri, 03/21/25 - 11:38 am
clinical trials
WHO
Public Health
Eisai's abandoned Enhertu challenger set to live on at BlissBio
Fierce Biotech
Fri, 03/21/25 - 11:34 am
Eisai
BB-1701
Bliss Bio
liquid biopsy

Pages